Ashraf Hanna is Director at Nexvet Biopharma plc (NVET). They have made 1 open-market trade across 1 company since 2016, most recently 2017-07-31.
CIK 0001632436
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5K since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NVET | 16,020 | $108K |
Shares reported on the most recent Form 4, priced at the 2017-07-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVET | BUY | 2016-03-02 | 2016-03-03 | $3.20 | $5K | -8.0% | -1.2% | +2.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.